Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1202249
Max Phase: Preclinical
Molecular Formula: C18H30BrNO
Molecular Weight: 275.44
Molecule Type: Small molecule
Associated Items:
ID: ALA1202249
Max Phase: Preclinical
Molecular Formula: C18H30BrNO
Molecular Weight: 275.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Br.CCCCN(CCCC)C1CCc2cccc(O)c2C1
Standard InChI: InChI=1S/C18H29NO.BrH/c1-3-5-12-19(13-6-4-2)16-11-10-15-8-7-9-18(20)17(15)14-16;/h7-9,16,20H,3-6,10-14H2,1-2H3;1H
Standard InChI Key: CBRHYVJLHIWODV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 275.44 | Molecular Weight (Monoisotopic): 275.2249 | AlogP: 4.15 | #Rotatable Bonds: 7 |
Polar Surface Area: 23.47 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.85 | CX Basic pKa: 10.74 | CX LogP: 4.40 | CX LogD: 2.31 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.81 | Np Likeness Score: -0.25 |
1. Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.. (1984) 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists., 27 (1): [PMID:6418888] [10.1021/jm00367a009] |
Source(1):